phospholipases A

Preferred Label : phospholipases A;

MeSH definition : Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.;

CISMeF synonym : a, phospholipases;

Registry Number MeSH : EC 3.1.1.-; EC 3.1.1.32;

MeSH annotation : general; prefer specifics;

Is substance : O;

UNII : EC 3.1.1.32;

Details

Origin ID

D010741;

UMLS CUI

C0031672;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cytosolic Phospholipase A2 [NCIt concept]
- Phospholipase [NCIt concept]
- Phospholipase (substance) [SNOMED CT concept]
- Phospholipase A2 [NCIt concept]
- Phospholipase A2 Enzyme Family [NCIt concept]
- Phospholipase A>2< (substance) [SNOMED CT concept]
- phospholipase A2 activity [GO term]
- phospholipase a2 [SNOMED Notion]
- phospholipase c [SNOMED Notion]
- phospholipase d [SNOMED Notion]
Indexing information
- 1-(4'-methoxybenzoyl)-2-n-tridecylpiperazine [MeSH Supplementary Concept]
- 1-(benzylmethylamino)-3-(alpha,alpha,alpha-trifluoro-3-tolyl)oxy-2-propanol [MeSH Supplementary Concept]
- 1-(hexylthio) -2-(hexanoylamino)-1,2-dideoxy-sn-glycero-3-phosphoethanolamine [MeSH Supplementary Concept]
- 1-(hexylthio)-2-(hexanoylamino)-1,2-dideoxy-sn-glycero-3-phosphocholine [MeSH Supplementary Concept]
- 1-decyl 2-octyl-glycerophosphocholine [MeSH Supplementary Concept]
- 1-dodecyl-2-octanamido-sn-2-deoxyglycero-3-phosphocholine [MeSH Supplementary Concept]
- 1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol [MeSH Supplementary Concept]
- 1-hexylthio-2-nonanoylamino-1,2-dideoxy-sn-glycero-3-phosphocholine [MeSH Supplementary Concept]
- 1-nitrophenyl-octylphosphonate-2-tridecylcarbamoyl-3-ethanesulfonylamino-3-deoxyglycerol [MeSH Supplementary Concept]
- 1-octyl-2-(N-dodecanoylamino)-2-deoxyglycero-3-phosphoglycol [MeSH Supplementary Concept]
- 1-stearyl-2-stearoylaminodeoxyphosphatidylcholine [MeSH Supplementary Concept]
- 12-deacetyl-23-acetoxy-20-methylscalaradial [MeSH Supplementary Concept]
- 13-cis-12-(3'-carboxyphenyl)retinoic acid [MeSH Supplementary Concept]
- 2-(2',6'-dimethylocta-1,5,7-trienyl)furan-4-carboxylic acid [MeSH Supplementary Concept]
- 2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid [MeSH Supplementary Concept]
- 2-dodecanoylamino-1-hexanolphosphocholine [MeSH Supplementary Concept]
- 2-dodecanoylamino-1-hexanolphosphoglycol [MeSH Supplementary Concept]
- 2-nitrobenzenesulfonyl fluoride [MeSH Supplementary Concept]
- 2-tetradecanoylaminohexanol-1-phosphocholine [MeSH Supplementary Concept]
- 3-(4-octadecyl)benzoylacrylic acid [MeSH Supplementary Concept]
- 3-(7,10)hexadecadienyl-4-hydroxy-2-butenolide [MeSH Supplementary Concept]
- 3-dodecanoyl-4-phosphatidylcholinohydroxymethyl-2-oxazolidinone [MeSH Supplementary Concept]
- 3-dodecanoylindole-2-carboxylic acid [MeSH Supplementary Concept]
- 4-((2-oxododecanoyl)amino)octanoic acid [MeSH Supplementary Concept]
- 4-((2-oxohexadecanoyl)amino)butanoic acid [MeSH Supplementary Concept]
- 6-(1-bromoethylene)tetrahydro-3-(1-naphthenyl)-2H-pyran-2-one [MeSH Supplementary Concept]
- 6-(2-(2-carboxyethyl)-4--dodecanoyl-3,5-dimethylpyrrol-1-yl)nonanoic acid [MeSH Supplementary Concept]
- 6-(2-(2-carboxyethyl)-4-dodecanoyl-3,5-dimethylpyrrol-1-yl)hexanoic acid [MeSH Supplementary Concept]
- 6-bromo-2-(1-naphthyl)-5-oxohexanoic acid [MeSH Supplementary Concept]
- 6-methyl-4-((2-oxopentadecanoyl)amino)heptanoic acid [MeSH Supplementary Concept]
- BM 16.2224 [MeSH Supplementary Concept]
- BM 16.2266 [MeSH Supplementary Concept]
- BMS 229724 [MeSH Supplementary Concept]
- CGP 43182 [MeSH Supplementary Concept]
- CL 118326 [MeSH Supplementary Concept]
- EPACOCF3 [MeSH Supplementary Concept]
- ER 3826 [MeSH Supplementary Concept]
- FPL 67047XX [MeSH Supplementary Concept]
- GPLI-I protein, trimeresurus flavoviridis [MeSH Supplementary Concept]
- IP 3196 [MeSH Supplementary Concept]
- IS 741 [MeSH Supplementary Concept]
- LY 178002 [MeSH Supplementary Concept]
- LsPLIgamma-A protein, laticauda semifasciata [MeSH Supplementary Concept]
- LsPLIgamma-B protein, laticauda semifasciata [MeSH Supplementary Concept]
- MIP-I protein, cerrophidion godmani [MeSH Supplementary Concept]
- MIP-II protein, cerrophidion godmani [MeSH Supplementary Concept]
- NaI protein, notechis ater [MeSH Supplementary Concept]
- P-PB.III peptide [MeSH Supplementary Concept]
- PLIalpha [MeSH Supplementary Concept]
- PLIbeta protein, agkistrodon blomhoffii siniticus [MeSH Supplementary Concept]
- PX 13 [MeSH Supplementary Concept]
- SB 203347 [MeSH Supplementary Concept]
- SB 222657 [MeSH Supplementary Concept]
- SB-216477 [MeSH Supplementary Concept]
- SR 41319 [MeSH Supplementary Concept]
- U 10029A [MeSH Supplementary Concept]
- U 26384 [MeSH Supplementary Concept]
- WAY 121520 [MeSH Supplementary Concept]
- YM 26567-1 [MeSH Supplementary Concept]
- YM 26734 [MeSH Supplementary Concept]
- agkistrodon platelet aggregation inhibitor [MeSH Supplementary Concept]
- ammodytin I(2) [MeSH Supplementary Concept]
- ammodytin L [MeSH Supplementary Concept]
- ammodytoxin C [MeSH Supplementary Concept]
- basic protein I [MeSH Supplementary Concept]
- bilobetin [MeSH Supplementary Concept]
- ceratospongamide [MeSH Supplementary Concept]
- chloracizine [MeSH Supplementary Concept]
- cinatrin A [MeSH Supplementary Concept]
- cinatrin B [MeSH Supplementary Concept]
- cinatrin C1 [MeSH Supplementary Concept]
- cinatrin C2 [MeSH Supplementary Concept]
- cinatrin C3 [MeSH Supplementary Concept]
- dehydrotumulosic acid [MeSH Supplementary Concept]
- demethoxyviridin [MeSH Supplementary Concept]
- dodecyl-2-aminohexanol-1-phosphoglycol [MeSH Supplementary Concept]
- dodecylphosphocholine [MeSH Supplementary Concept]
- duramycin B [MeSH Supplementary Concept]
- duramycin C [MeSH Supplementary Concept]
- dysidenone A [MeSH Supplementary Concept]
- dysidenone B [MeSH Supplementary Concept]
- dysidine [MeSH Supplementary Concept]
- ecopladib [MeSH Supplementary Concept]
- euplexide F [MeSH Supplementary Concept]
- euplexide G [MeSH Supplementary Concept]
- folipastatin [MeSH Supplementary Concept]
- gravidin [MeSH Supplementary Concept]
- heliodermin [MeSH Supplementary Concept]
- indolizine inhibitor 120-1032 [MeSH Supplementary Concept]
- indoxam [MeSH Supplementary Concept]
- lipomodulin [MeSH Supplementary Concept]
- manoalide [MeSH Supplementary Concept]
- manoalogue [MeSH Supplementary Concept]
- methyl arachidonylfluorophosphonate [MeSH Supplementary Concept]
- morelloflavone [MeSH Supplementary Concept]
- nigexine [MeSH Supplementary Concept]
- pachymic acid [MeSH Supplementary Concept]
- palmitoyl trifluoromethyl ketone [MeSH Supplementary Concept]
- penidiamide [MeSH Supplementary Concept]
- petrosaspongiolide R [MeSH Supplementary Concept]
- petrosaspongiolide m [MeSH Supplementary Concept]
- phospholipase A2 inhibitor protein, crotalus [MeSH Supplementary Concept]
- phospholipase A2-activating protein [MeSH Supplementary Concept]
- plastatin [MeSH Supplementary Concept]
- plipastatin [MeSH Supplementary Concept]
- rosenthal's inhibitor [MeSH Supplementary Concept]
- surfactin peptide [MeSH Supplementary Concept]
- taipoxin [MeSH Supplementary Concept]
- thielocin A1alpha [MeSH Supplementary Concept]
- thielocin A1beta [MeSH Supplementary Concept]
- thielocin B3 [MeSH Supplementary Concept]
- varespladib [MeSH Supplementary Concept]
- zanhasaponin A [MeSH Supplementary Concept]
- zanhasaponin B [MeSH Supplementary Concept]
Record concept(s)
- phospholipases A [MeSH concept]
Related MeSH Supplementary Concept(s)
- AT1G67750 protein, arabidopsis [MeSH Supplementary Concept]
- Cdr-12 protein, crotalus durissus ruruima [MeSH Supplementary Concept]
- Cdr-13 protein, crotalus durissus ruruima [MeSH Supplementary Concept]
- DONGLE protein, arabidopsis [MeSH Supplementary Concept]
- KLM 583B [MeSH Supplementary Concept]
- Ldh1 protein, S cerevisiae [MeSH Supplementary Concept]
- Lpx1 protein, S cerevisiae [MeSH Supplementary Concept]
- MiPLA-4 protein, micropechis ikaheka [MeSH Supplementary Concept]
- PLAAT1 protein, human [MeSH Supplementary Concept]
- api m 1 allergen, apis mellifera [MeSH Supplementary Concept]
- myotoxin II, bothrops moojeni [MeSH Supplementary Concept]
- pPLAIIIdelta protein, arabidopsis [MeSH Supplementary Concept]
- plaat1 protein, zebrafish [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
Validated automatic mappings to NTBT
- Phospholipase [LOINC component]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients